Skip to content
Screener

ICU Medical ICUI Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$548.9MBeat by $37.4M
EPS$2.10Beat by $0.66
Revenue estimate$511.5M
EPS estimate$1.44

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$552.1M
EPS estimate$2.13

Financials

Q2 2025

Income statement

See full
Revenue$548.9M-8.0%
Gross profit$208.1M+0.3%
Operating income$10.6M+37.6%
Net income$35.3M+265%
EPS (diluted)$1.43+263%

Balance sheet

See full
Cash & equivalents$300.0M-0.9%
Total debt$1.4B-18.8%
Total equity$2.1B+3.8%
Total assets$4.1B-4.2%

Cash flow

See full
Operating cash flow$11.2M-86.3%
CapEx$19.7M+1.2%
Free cash flow--100%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$3.22B+12.0%
Enterprise value$4.33B+0.5%
P/S1.4×+0.1×

Profitability

See full
Gross margin35.8%+3.4pp
Operating margin2.9%—
Net margin-1.6%-0.5pp
FCF margin2.9%-4.4pp

Returns & leverage

See full
Return on equity-1.8%-0.6pp
Debt / equity0.7×-0.2×
Current ratio2.4×0.0×

Segments

By geography

See full
UNITED STATES$335.4M—
APAC$58.2M—

FAQ

When did ICU Medical report Q2 2025 earnings?
ICU Medical (ICUI) reported Q2 2025 earnings on August 7, 2025 after market close.
What were ICU Medical's Q2 2025 revenue and EPS?
ICU Medical reported revenue of $548.9M and eps of $2.10 for Q2 2025.
Did ICU Medical beat estimates in Q2 2025?
Revenue beat the consensus estimate of $511.5M by $37.4M. EPS beat the consensus estimate of $1.44 by $0.66.
How did ICU Medical's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.0% from $596.5M a year earlier and eps grew 34.6% from $1.56.
Where can I find ICU Medical's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000883984-25-000029) and the 10-Q periodic report (0000883984-25-000030) directly on SEC EDGAR. The filing index links above go to sec.gov.